The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Pharm to Farm Ltd

4 Mar 2021 07:00

RNS Number : 1015R
Remote Monitored Systems PLC
04 March 2021
 

4 March 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Remote Monitored Systems plc

("RMS" or the "Company")

Update on Pharm to Farm Ltd ("P2F")

The Company is pleased to report the significant progress achieved since the announcement on 18 February. 

· Order for 1.0 million of P2F's masks placed with Volz with outsourcing manufacturing discussions in progress

· Distribution agreement to make masks available in UK & Europe via Amazon

· Launch of web site for the P2F mask

· Independent adviser and line manager appointed to bring mask machine into full operation

Further to previous announcements in relation to discussions the Company has held with the Volz Group of Companies ("Volz"), an initial order has been placed for one million of P2F's masks, incorporating P2F's proprietary antiviral material (α-virion), and discussions are under way to extend this into a production outsourcing arrangement to increase the supply of the anti-viral masks. Not only should this approach enable the expected demand for the mask to be met but it will also allow P2F to focus on its core strengths of developing and producing nanomaterials and associated innovative products.

Whilst interest in the masks has been strong, it was important to ensure that potential supply issues had been resolved before committing to deliveries. On the back of the discussions with Volz, P2F has entered into a distribution agreement with Francis McIntyre Limited, an online garment retailer with the brand FM London, ("Francis McIntyre") to make P2F's masks available to customers across the UK and Europe via the Amazon E-commerce platform ("Amazon"). Under the terms of the agreement, Francis McIntyre has placed an initial order for 100,000 masks, with the exclusive right to sell via Amazon being conditional upon Francis McIntyre ordering a minimum of 1 million masks per month. P2F has also started supplying batches of between 5,000 and 10,000 masks to a number of customers looking to trial the product ahead of potentially placing larger orders in the future. A dedicated website for the mask has been created (www.pro-larva.com) and is expected to go live by the end of this week, which should help drive further demand.

P2F is in discussions with Lemu Group, the manufacturer of the mask making machine, regarding mechanical issues that need to be resolved before the machine at BioCity can be considered to be fully commissioned. The Company has agreed to appoint Egremont Capital Limited ("Egremont") as an independent advisor for the next three months to assist with development of P2F's production capabilities. Jonathan Hall, Egremont's founder, has a background in production manufacturing, in addition to Egremont's expertise as a corporate advisor. In addition to a monthly fee, Egremont may be issued with up to 500,000 new ordinary shares dependent on achieving certain production milestones. In addition, a line manager has been recruited at BioCity to strengthen the production team. 

Antony Legge, Executive Chairman of RMS, said; "We are very pleased to update the market with the positive developments achieved by the P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement, means P2F can commence sales with confidence as we anticipate a continuing market need for P2F's proprietary α-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes."

 

- ENDS -

 

ENQUIRIES:

Remote Monitored Systems plc

Antony Legge (Executive Chairman) via IFC Advisory

 

SP Angel Corporate Finance LLP +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

Peterhouse Capital Limited +44 20 7469 0930

Joint Broker

Lucy Williams

 

IFC Advisory Ltd +44 20 3934 6630

Graham Herring

Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAEDDEDFFEAA
Date   Source Headline
16th Dec 20202:11 pmRNSPharm 2 Farm Update
15th Dec 202011:44 amRNSPharm 2 Farm Update
14th Dec 20207:00 amRNSPharm 2 Farm Update
11th Dec 202012:00 pmRNSPharm 2 Farm Update
30th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Nov 20202:06 pmRNSSecond Price Monitoring Extn
30th Nov 20202:00 pmRNSPrice Monitoring Extension
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20202:00 pmRNSPrice Monitoring Extension
26th Nov 20209:05 amRNSSecond Price Monitoring Extn
26th Nov 20209:00 amRNSPrice Monitoring Extension
26th Nov 20207:00 amRNSUpdate on P2F
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
19th Nov 20209:05 amRNSSecond Price Monitoring Extn
19th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20206:07 pmRNSHolding(s) in Company
18th Nov 20205:52 pmRNSDirector Dealing
18th Nov 20209:05 amRNSSecond Price Monitoring Extn
18th Nov 20209:00 amRNSPrice Monitoring Extension
17th Nov 20205:27 pmRNSHolding(s) in Company
17th Nov 20202:05 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
17th Nov 20209:06 amRNSSecond Price Monitoring Extn
17th Nov 20209:00 amRNSPrice Monitoring Extension
17th Nov 20207:01 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSDirector Dealing
16th Nov 20202:06 pmRNSSecond Price Monitoring Extn
16th Nov 20202:01 pmRNSPrice Monitoring Extension
16th Nov 20209:05 amRNSSecond Price Monitoring Extn
16th Nov 20209:00 amRNSPrice Monitoring Extension
16th Nov 20207:30 amRNSPharm 2 Farm Update and Issue of Equity
16th Nov 20207:00 amRNSPharm 2 Farm Update
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 202011:06 amRNSSecond Price Monitoring Extn
13th Nov 202011:00 amRNSPrice Monitoring Extension
13th Nov 20209:06 amRNSSecond Price Monitoring Extn
13th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20203:28 pmRNSExercise of Warrants and Funding Update
12th Nov 202011:40 amRNSHolding(s) in Company
12th Nov 202011:06 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
11th Nov 20204:41 pmRNSSecond Price Monitoring Extn
11th Nov 20204:36 pmRNSPrice Monitoring Extension
11th Nov 20202:05 pmRNSSecond Price Monitoring Extn
11th Nov 20202:00 pmRNSPrice Monitoring Extension
11th Nov 202010:59 amRNSPharm 2 Farm Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.